Study about schizophrenia patients’ experiences in a research program
Part of Mental health clinical trials.
This trial asks people who have schizophrenia to share their experience doing study activities, and it tests whether the study procedures work well for patients. It may help improve how future schizophrenia studies are run.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a diagnosis of schizophrenia
- You can understand the study and reliably do all study activities
- You are willing to sign written consent to join
- You are not currently in another drug study and have not recently finished or stopped one involving an investigational drug
- You are not pregnant, breastfeeding, or planning to conceive during the study period
- You do not have a serious or unstable medical condition that could interfere with the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how people with schizophrenia experience the process of joining and participating in clinical trials. It may help improve how future trials are explained and supported for patients.
This study builds a database and collects samples (like blood) from people with schizophrenia to learn more about the condition. If you join, you help researchers understand schizophrenia better, which may lead to improved treatments.
This study looks at brain chemicals involved in “glutamate” and “GABA” signaling in people with schizophrenia (and separately in healthy volunteers). It may help researchers understand what’s going wrong in the brain and guide future treatments.
This trial is studying mental health across the daily life of people living in the community who have schizophrenia. It may help by improving how care is planned and supported over time for people living in Shanghai.
This is an observational (non-intervention) study that follows adults with schizophrenia who are taking specific “atypical” antipsychotic medicines long-term. Researchers want to learn about patients’ experiences and outcomes while on these treatments.
This study looks at people who have had psychosis for less than 4 years to understand how their symptoms change over time and how they respond to treatment. By using brain scans and other tests, researchers hope to find better ways to personalize care for early psychosis.
Hear when a new Schizophrenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.